EUVIMEDEUVIMED entdecken
Crossref

SARM1 deletion delays cerebellar but not spinal cord degeneration in an enhanced mouse model of SPG7 deficiency

Carolina Montoro-Gámez, Hendrik Nolte, Thibaut Molinié, Giovanna Evangelista, Simon E Tröder, Esther Barth, Milica Popovic, Aleksandra Trifunovic iD, Branko Zevnik, Thomas Langer, Elena I Rugarli iD

Brain · 2023

DOI: 10.1093/brain/awad136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2023. Verfasst von Carolina Montoro-Gámez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Genetics, University of Cologne, Cologne 50931, Germany. Hauptthemen laut MEDLINE: Spastic Paraplegia, Hereditary. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Bundesministerium für Forschung und Bildung, TreatHSP, Deutsche Forschungsgemeinshaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary spastic paraplegia is a neurological condition characterized by predominant axonal degeneration in long spinal tracts, leading to weakness and spasticity in the lower limbs. The nicotinamide adenine dinucleotide (NAD+)-consuming enzyme SARM1 has emerged as a key executioner of axonal degeneration upon nerve transection and in some neuropathies. An increase in the nicotinamide mononucleotide/NAD+ ratio activates SARM1, causing catastrophic NAD+ depletion and axonal degeneration. However, the role of SARM1 in the pathogenesis of hereditary spastic paraplegia has not been investigated. Here, we report an enhanced mouse model for hereditary spastic paraplegia caused by mutations in SPG7. The eSpg7 knockout mouse carries a deletion in both Spg7 and Afg3l1, a redundant homologue expressed in mice but not in humans. The eSpg7 knockout mice recapitulate the phenotypic features of human patients, showing progressive symptoms of spastic-ataxia and degeneration of axons in the spinal cord as well as the cerebellum. We show that the lack of SPG7 rewires the mitochondrial proteome in both tissues, leading to an early onset decrease in mito-ribosomal subunits and a remodelling of mitochondrial solute carriers and transporters. To interrogate mechanisms leading to axonal degeneration in this mouse model, we explored the involvement of SARM1. Deletion of SARM1 delays the appearance of ataxic signs, rescues mitochondrial swelling and axonal degeneration of cerebellar granule cells and dampens neuroinflammation in the cerebellum. The loss of SARM1 also prevents endoplasmic reticulum abnormalities in long spinal cord axons, but does not halt the degeneration of these axons. Our data thus reveal a neuron-specific interplay between SARM1 and mitochondrial dysfunction caused by lack of SPG7 in hereditary spastic paraplegia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spastic Paraplegia, HereditaryAnimalsHumansMiceArmadillo Domain ProteinsATPases Associated with Diverse Cellular ActivitiesAxonsCerebellumCytoskeletal ProteinsMetalloendopeptidasesNAD

Stichwörter der Autor:innen

axonal degenerationcerebellummitochondriaparapleginspinal cord

Substanzen

Afg3l1 protein, mouseArmadillo Domain ProteinsATPases Associated with Diverse Cellular ActivitiesCytoskeletal ProteinsMetalloendopeptidasesNADSARM1 protein, mouseSpg7 protein, mouse

Autor:innen und Institutionen

  • Institute for Genetics, University of Cologne, Cologne 50931, Germany.
  • Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne 50931, Germany.
  • Max Planck Institute for Biology of Ageing, Cologne 50931, Germany.
  • in vivo Research Facility, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne 50931, Germany.
  • Institute for Mitochondrial Diseases and Aging, Medical Faculty, University of Cologne, Cologne 50931, Germany.
  • Center for Molecular Medicine (CMMC), University of Cologne, Cologne 50931, Germany.

ORCID-Profile: Aleksandra Trifunovic, Elena I Rugarli

Förderung

  • Bundesministerium für Forschung und Bildung
  • TreatHSP
  • Deutsche Forschungsgemeinshaft
  • PROSPAX
  • European Joint Program on Rare Diseases
  • C.M.G. and E.I.R.

Zitieren

APA

Montoro-Gámez, C., Nolte, H., Molinié, T., Evangelista, G., Tröder, S. E., Barth, E., Popovic, M., Trifunovic, A., Zevnik, B., Langer, T., & Rugarli, E. I. (2023). SARM1 deletion delays cerebellar but not spinal cord degeneration in an enhanced mouse model of SPG7 deficiency. Brain. https://doi.org/10.1093/brain/awad136

Vancouver

Montoro-Gámez C, Nolte H, Molinié T, Evangelista G, Tröder SE, Barth E, et al. SARM1 deletion delays cerebellar but not spinal cord degeneration in an enhanced mouse model of SPG7 deficiency. Brain. 2023. doi:10.1093/brain/awad136

BibTeX
@article{MontoroGmez2023,
  author = {Montoro-Gámez, Carolina and Nolte, Hendrik and Molinié, Thibaut and Evangelista, Giovanna and Tröder, Simon E and Barth, Esther and Popovic, Milica and Trifunovic, Aleksandra and Zevnik, Branko and Langer, Thomas and Rugarli, Elena I},
  title = {SARM1 deletion delays cerebellar but not spinal cord degeneration in an enhanced mouse model of SPG7 deficiency},
  journal = {Brain},
  year = {2023},
  doi = {10.1093/brain/awad136}
}
Kostenlos starten →